Tag: investor conference

FDA Approves BRINSUPRI™ (brensocatib) as the First and Only Treatment for Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease

— Approximately 500,000 U.S. Patients Are Diagnosed with Non-Cystic Fibrosis Bronchiectasis (NCFB), a Progressive Disease That Can Lead to Permanent Lung Damage — — BRINSUPRI 10...

AmpliTech Group To Release Q2 – 2025 Earnings On August 14th After Market Also Announces Investor’s Conference Call

RumbleOn, Inc. Reports Second Quarter 2025 Financial Results

Rebranding Initiative, including Name Change to RideNow Group, Inc., Corporate Headquarters Relocation Back to Phoenix, AZ Area, and Ticker Symbol Change Amends, Reprices and Extends...

Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events

STAFFORD, Texas, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on the development of GLSI-100, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today provided the following update on CEO interviews and corporate events.

Commerce to Present at Upcoming Investor Conference

AUSTIN, Texas, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Commerce.com, Inc. (Nasdaq: CMRC) (formerly BigCommerce Holdings, Inc.), a provider of an open, intelligent ecosystem of technology solutions that empower businesses to unlock data potential and deliver seamless, personalized experiences at scale, today announced the following upcoming investor conference presentation:

Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025

Company to host an investor conference call and webcast at 4:30 pm ET

Company to host an investor conference call and webcast at 4:30 pm ET

SIGMA LITHIUM STREAMLINES LEADERSHIP COMBINING KEY ROLES UNDER VETERAN VPs; ANNOUNCES SHAREHOLDER MEETING RESULTS; TO RELEASE 2Q FINANCIALS ON AUG 14, 2025

HIGHLIGHTS Sigma Lithium announces a consolidation of its core leadership roles, as it evolved into one of the world's major "pure-play" lithium producers, on track...

OTCQB Venture Virtual Investor Conference: Presentations Now Available for Online Viewing

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com

KOPPERS REPORTS SECOND QUARTER 2025 RESULTS; REVISES 2025 OUTLOOK

Sales of $504.8 Million vs. $563.2 Million in Prior Year QuarterNet income attributable to Koppers of $16.4 Million vs. $26.8 Million in Prior Year...

VitalHub Reports Second Quarter 2025 Results

Annual Recurring Revenue (ARR)⁽¹⁾ up 55% YoY to $79.6 million
Total Revenue up 47% YoY to $23.9 million
Adjusted EBITDA⁽¹⁾ up 50% YoY to $6.3 million

CAPREIT Reports Second Quarter 2025 Results

TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Canadian Apartment Properties Real Estate Investment Trust ("CAPREIT") (TSX: CAR.UN) announced today its operating and financial results for the three and six months ended June 30, 2025. Management will host a conference call to discuss the financial results on Friday, August 8, 2025 at 9:00 a.m. ET.

NextGen Digital Platforms Inc. to Present at the OTCQB Venture Virtual Investor Conference August 7th

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

EnerCom Announces Andrew Rapp, Senior Advisor in the U.S. Department of Energy, as Keynote Speaker on August 18th at EnerCom’s 30th Anniversary Energy Investment...

Qualified Investors and Analysts Can Register at No Cost at www.enercomdenver.com Deadline to Submit One-on-One Meeting Requests to Presenting Companies is Friday, August 8th Registration still...

Release of Marimekko’s Half-year Financial Report, 1 January–30 June 2025

Marimekko Corporation, Press release 6 August 2025 at 1.30 p.m. EEST

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsInvestor conference

Lilly’s Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with...

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

TAIWAN DESIGN POWER Debuts at Busan Design Festival, Showcasing Taiwan’s Design Innovation and Creative Value